Business summary

Shima Ophthalmology Holdings is one of the leading ophthalmology service providers in Hong Kong and Guangdong Province. It was founded under the “Shimalin Shunchao” brand and is headquartered in Hong Kong. It is the first foreign investor to establish an independent ophthalmology hospital in China. The group provides diagnosis and treatment services for eye diseases including cataracts, corneal and surface diseases, glaucoma, vitreous retinal and macular disease, as well as acupuncture and traditional Chinese medicine to assist in the treatment of eye diseases. Currently, there are nine ophthalmologists in Hong Kong. Dr. Chao and 29 Chinese doctors.

Competitive advantage

Provide international standard comprehensive ophthalmology services to treat various common eye diseases and difficult problems

The group is led by a team of ophthalmologists, able to focus on quality of service and risk factors experienced by patients

Rely on the leadership and services of Dr. Lam Shun-chiu, the Group's Chairman, Chief Executive Officer and Executive Director

Significant costs are incurred due to retention of services provided by ophthalmologists in Hong Kong and China

Claims of medical incidents, medical negligence or misconduct may adversely affect the Group's business and financial position, operating performance and business prospects

Use of proceeds

Approximately 42.5% was used for the potential acquisition of three ophthalmology hospitals operating in selected Chinese cities

Approximately 40.4% was used to establish three eye hospitals in selected Chinese cities

Approximately 4.2% was used to open two satellite clinics in Shenzhen, China

Approximately 8.5% was used to upgrade the group's medical equipment and enhance the IT systems in Hong Kong and China

Approximately 4.4% is used for general working capital